![]() |
市場調查報告書
商品編碼
2021530
種子技術創新市場預測至2034年—按產品類型、性狀、作物類型、應用、最終用戶和地區分類的全球分析Seed Technology Innovations Market Forecasts to 2034 - Global Analysis By Product Type, Trait, Crop Type, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,2026 年全球種子技術創新市場價值將達到 684 億美元,預計在預測期內將以 10.1% 的複合年成長率成長,到 2034 年達到 1,486 億美元。
種子技術創新是指先進的植物育種調查方法、基因修飾平台、分子標記系統和精準編輯技術,例如基於CRISPR的基因組編輯、標記輔助選擇、基因改造作物開發和計算基因組學。這些技術應用於培育具有更高產量、更強非生物脅迫耐受性、更強抗病性、更高營養價值和更高投入利用效率的商業性優良作物品種,從而顯著提高不同種植系統和地區農民的農業生產力和永續性。
投資糧食安全的迫切性
氣候變遷導致作物產量波動、人口營養需求不斷成長以及耕地資源有限,加劇了全球糧食安全挑戰,促使公共和私營部門迫切投資於先進種子技術研發,以維持全球作物生產力成長趨勢。政府對農業研究的資助以及對國際糧食安全項目的投資,使得小麥、水稻、玉米和大豆等主要糧食作物對耐旱、抗病和高產種子品種的需求持續圖。
基因改造作物面臨的監管障礙
歐盟市場對基改作物嚴格的核准要求,以及許多開發中國家監管的不確定性,導致基改作物的核准流程耗時多年,監管投入龐大,從而限制了基改種子技術的地域覆蓋範圍,並將商業性利益集中在已建立基改作物法規結構的市場。此外,儘管基因改造作物已被證明具有農業效益,但歐洲主要消費市場消費者對基因改造生物的懷疑態度也限制了商業化基因改造種子的普及。
CRISPR種子創新管道
基於CRISPR技術的精準育種創新流程正在關鍵市場創造巨大的商業機遇,包括美國、日本以及日益重要的巴西。在這些市場,基因編輯作物比基因改造品種享有更優惠的監管待遇。這使得精準編輯的作物性狀(例如抗病性、耐旱性和更高的營養價值)能夠更快地商業性,從而在允許非基因改造基因組的法規結構內,為農民帶來他們所重視的性能優勢。
自留種子做法的衰落
農民保存種子的做法以及日益壯大的開放原始碼植物育種運動對商業性種子技術公司構成了收入威脅。捍衛農民種子權和獲取非專有品種的運動正在產生市場和監管壓力,這可能會限制先進種子技術創新智慧財產權保護的期限和範圍。因此,私部門在某些作物改良優先領域的育種計畫的商業性獎勵報酬率將會降低。
新冠疫情導致的種子供應鏈中斷,使得多個農業市場在播種季節出現種子短缺,暴露了農民對集中式商業種子供應鏈的依賴,並加速了對種子系統韌性的投資。疫情期間,人們對糧食安全的日益關注,促使政府和投資部門更加重視透過先進種子技術提高農業生產力。後疫情時代,對農業永續性的投資動能持續強勁,為私人育種計畫和公共農業研究機構的種子技術創新提供了資金支持。
在預測期內,基因編輯種子片段預計將是規模最大的。
預計在預測期內,基因編輯種子領域將佔據最大的市場佔有率。這主要歸功於CRISPR編輯作物品種商業化的快速推進,這些品種在主要市場享有有利的監管環境,使其商業化速度比基因改造品種更快。此外,具有增產和抗逆性等優勢的高性能、精準編輯品種正受到農民的廣泛青睞,其銷售價格也因此水漲船高,而更高的農業效益也為其帶來了豐厚的回報。
預計在預測期內,抗除草劑作物細分市場將呈現最高的複合年成長率。
在預測期內,除草劑耐受性種子市場預計將呈現最高的成長率,這主要得益於市場對與新型選擇性除草劑化學成分相容的新一代除草劑耐受性種子性狀的需求不斷成長。這一成長的驅動力在於,隨著雜草控制壓力日益成為北美、南美和亞太地區主要農作物市場作物生產力和種子技術選擇決策的主要促進因素,農民擴大採用包含高耐除草劑品種的雜草管理系統。
在預測期內,北美預計將佔據最大的市場佔有率。這是因為美國是全球最大的商業種子市場,其玉米、大豆、棉花和菜籽生產系統廣泛採用先進的基因改造和分子育種技術,而且像科迪華農業科技、拜耳作物科學和先正達這樣的領先種子技術創新企業也貢獻了全球大部分先進種子技術研發和商業收入。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要歸功於印度、中國、印尼和越南實施了雄心勃勃的作物生產力提升計劃,這些計劃融合了先進的雜交育種和分子育種技術,應用於水稻、小麥、蔬菜和棉花等作物;同時,這些國家還提高了國內種子技術研發能力,並透過擴大農村分銷網路,增加了農民獲得改良商業種子品種的途徑。
According to Stratistics MRC, the Global Seed Technology Innovations Market is accounted for $68.4 billion in 2026 and is expected to reach $148.6 billion by 2034 growing at a CAGR of 10.1% during the forecast period. Seed technology innovations refer to advanced plant breeding methodologies, genetic enhancement platforms, molecular marker systems, and precision editing technologies including CRISPR-based genomic editing, marker-assisted selection, transgenic trait development, and computational genomics applied to develop commercially superior crop seed varieties with enhanced yield performance, abiotic stress tolerance, disease resistance, nutritional quality, and input-use efficiency that deliver measurable agricultural productivity and sustainability improvements to farmers across diverse cropping systems and geographies.
Food Security Investment Urgency
Global food security challenges intensified by climate-driven crop yield volatility, growing population nutritional demands, and arable land constraints are driving urgent public and private investment in advanced seed technology development to maintain global crop productivity trajectory. Government agricultural research funding commitments and international food security program investments are generating sustained demand for drought-tolerant, disease-resistant, and yield-enhanced seed varieties across major staple crop categories including wheat, rice, maize, and soybean.
GM Crop Regulatory Barriers
Stringent genetically modified crop regulatory approval requirements across European Union markets and regulatory uncertainty in multiple developing economy jurisdictions create multi-year commercialization timelines and substantial regulatory investment requirements that limit genetic seed technology adoption geography and concentrate commercial benefit in markets with established GM crop regulatory frameworks. Consumer skepticism toward genetically modified organisms in key European consumer markets restricts commercial GM seed deployment despite demonstrated agronomic benefits.
CRISPR Seed Innovation Pipeline
CRISPR-based precision breeding innovation pipeline is creating a substantial commercial opportunity as the more favorable regulatory treatment of genomic-edited crops compared to transgenic GM varieties in key markets including the United States, Japan, and increasingly Brazil enables faster commercialization timelines for precision-edited crop traits including disease resistance, drought tolerance, and nutritional quality enhancement that deliver farmer-valued performance benefits within regulatory frameworks accommodating non-transgenic genome modifications.
Seed Saving Practice Erosion
Farmer seed saving practices and growing open-source plant breeding movements represent commercial revenue threats to commercial seed technology companies as advocacy for farmer seed rights and alternative non-proprietary variety access creates market and regulatory pressure that may limit intellectual property protection duration and scope for advanced seed technology innovations, reducing commercial return-on-investment incentives for private sector breeding program investment in specific crop improvement priority areas.
COVID-19 seed supply chain disruptions generating planting season input shortages in multiple agricultural markets exposed farmer dependence on concentrated commercial seed supply chains and accelerated seed system resilience investment. Pandemic-era food security attention elevated political and investment priority for agricultural productivity enhancement through advanced seed technology. Post-pandemic agricultural sustainability investment momentum continues supporting seed technology innovation funding across both private breeding programs and public agricultural research institutions.
The genomic-edited seeds segment is expected to be the largest during the forecast period
The genomic-edited seeds segment is expected to account for the largest market share during the forecast period, due to rapidly expanding commercial pipeline of CRISPR-edited crop varieties receiving favorable regulatory treatment in major markets enabling faster commercialization compared to transgenic alternatives, combined with strong farmer adoption of high-performance precision-edited varieties delivering demonstrable yield and stress tolerance benefits that command premium seed prices justified by improved agronomic outcomes.
The herbicide tolerance segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the herbicide tolerance segment is predicted to witness the highest growth rate, driven by expanding demand for next-generation herbicide-tolerant seed traits compatible with newer selective herbicide chemistries as farmer adoption of weed management systems incorporating advanced herbicide-tolerant varieties continues growing across major row crop markets in North America, South America, and Asia Pacific where weed pressure management represents a primary driver of crop productivity and seed technology selection decisions.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States representing the world's largest commercial seed market with extensive adoption of advanced GM and molecular breeding technologies across corn, soybean, cotton, and canola production systems, combined with leading seed technology innovators including Corteva Agriscience, Bayer Crop Science, and Syngenta generating the majority of global advanced seed technology research and commercial revenue.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to India, China, Indonesia, and Vietnam implementing ambitious crop productivity improvement programs incorporating advanced hybrid and molecular breeding seed technologies for rice, wheat, vegetables, and cotton crops, combined with growing domestic seed technology development capability and expanding farmer access to improved commercial seed varieties through expanding rural distribution networks.
Key players in the market
Some of the key players in Seed Technology Innovations Market include Bayer AG, Corteva Agriscience, Syngenta AG, BASF SE, Limagrain Group, KWS SAAT SE & Co. KGaA, Sakata Seed Corporation, DLF Seeds A/S, Advanta Seeds, Rijk Zwaan, Enza Zaden, Nuziveedu Seeds Ltd., UPL Limited, Mahindra Agri Solutions, Takii & Co., Ltd., Vilmorin & Cie, and FMC Corporation.
In March 2026, Corteva Agriscience launched a new CRISPR-edited drought-tolerant corn hybrid delivering significant yield advantages under water-limited growing conditions compared to conventional hybrid varieties in key U.S. Corn Belt markets.
In February 2026, Syngenta AG introduced a new generation of marker-assisted soybean varieties with combined soybean cyst nematode resistance and improved yield potential targeting Midwest U.S. and Brazilian production systems.
In January 2026, Bayer AG announced commercial launch of precision-edited wheat varieties with enhanced disease resistance to Fusarium head blight for European and North American markets, pending final regulatory approvals.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.